Table 5 Comparison between patients’ number, clinical stages, grades, and tumor type, in our studies and other series
From: Upper Egypt experience in bladder preservation using concurrent chemoradiotherapy
Arias, et al., 2000 [6] | Caffo et al., 2003 [8] | Caffo et al., 2003 [8] | Sakr et al., 2003 [9] | Soliman et al., 2004 [10] | Group A | Group B | |
|---|---|---|---|---|---|---|---|
Patients number | 50 | 415 | 16 | 30 | 25 | 30 | 30 |
Tumor type | TCC | TCC | TCC | Mixed (TCC & SCC) | TCC | TCC | Mixed |
T1 | _____ | 21% | _____ | _____ | ______ | _____ | ______ |
T2 | 68% | 51% | 88.9% | 53.4% | 48% | 36.6% | 90% |
T3 | 32% | 7% | _____ | 46.6% | 52% | 59.9% | 10% |
T4a | _____ | ____ | 11.1% | ______ | _______ | 3.3% | _______ |
GI | 10% | ______ | unknown | ______ | _______ | _____ | 36.7% |
GII | 40% | 47.5% | unknown | 76.6% | 60% | 60% | 33.3% |
GIII | 50% | 52.5% | unknown | 23.4% | 40% | 40% | 30% |